Exponentiation In Innovation To Drive The Human Insulin Market

1
Human Insulin Market
Report Id PMRREP3308 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
Exponentiation In Innovation To Drive The Human
Insulin Market

• According to a new market report published by
  Persistence Market Research Global Market Study
  on Human Insulin Asia Pacific to Witness fastest
  Growth by 2020, the global human insulin market
  was valued at USD 24,332.6 million in 2014 and
  was expected to grow at a CAGR of 12.4 from 2014
  to 2020, to reach an estimated value of USD
  49,197.3 million in 2020.
• Globally, the human insulin market is witnessing
  significant growth due to increasing prevalence
  of diabetes and increasing awareness among people
  about diabetes care. In addition, technological
  advancements in insulin delivery devices and
  increasing prevalence of lifestyle related
  disorders such as obesity are also driving the
  growth of the market. However, uneven pricing and
  limited access to human insulin in emerging
  countries such as Brazil, India, and China are
  inhibiting the growth of the human insulin
  market. In addition, strict regulatory
  requirements for drug approval are also
  restraining the growth of the market. The global
  human insulin market was anticipated to grow from
  an estimated USD 24,332.6 million in 2014 to USD
  49,197.3 million in 2020 at a CAGR of 12.4
  during the forecast period.

Get Sample Copy of this Report_at_
https//www.persistencemarketresearch.com/samples/
3308
4
Key Trends

• In North America, increasing prevalence of
  diabetes with growing age and availability of
  advanced human insulin infusion devices are
  driving the use of human insulin in the market. 
• In Europe, the human insulin market is driven by
  rising aging population and increasing prevalence
  of diabetes. In addition, in Germany the market
  is evolving due to rising prevalence of diabetes
  and increasing awareness among people about
  diabetes care. However, in Asia-Pacific the
  growth for human insulin is much higher than
  developed countries due to increasing prevalence
  of diabetes and increasing government initiatives
  for improving healthcare.
• Novo Nordisk A/S, Eli Lilly and Company, Sanofi,
  Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd.,
  Adocia, Merck Co., Inc., Pfizer, Inc.,
  Wockhardt, Julphar, Bristol-Myers Squibb Company,
  GlaxoSmithKline Plc and Oramed Pharmaceuticals,
  Inc. are some of the major players in human
  insulin market.

Access Full Report_at_ https//www.persistencemarketr
esearch.com/checkout/3308
5
(No Transcript)